SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093305
Filing Date
2024-08-08
Accepted
2024-08-08 07:10:12
Documents
91
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qttb-20240630.htm   iXBRL 10-Q 2683521
2 EX-31.1 qttb-ex31_1.htm EX-31.1 13547
3 EX-31.2 qttb-ex31_2.htm EX-31.2 13542
4 EX-32.1 qttb-ex32_1.htm EX-32.1 8366
5 EX-32.2 qttb-ex32_2.htm EX-32.2 8361
  Complete submission text file 0000950170-24-093305.txt   10843343

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20240630.xsd EX-101.SCH 1636361
94 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20240630_htm.xml XML 1722181
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38433 | Film No.: 241186009
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)